Proteomic profiling of advanced melanoma patients to predict therapeutic response to anti-PD-1 therapy. Zila N, Eichhoff OM, Steiner I, Mohr T, et al. Clin Cancer Res 2023 Oct 20. doi: 10.1158/1078-0432.CCR-23-0562.

Read + Share

Amedeo Smart

Independent Medical Education

Zila N, Eichhoff OM, Steiner I, Mohr T, et al. Proteomic profiling of advanced melanoma patients to predict therapeutic response to anti-PD-1 therapy. Clin Cancer Res 2023 Oct 20. doi: 10.1158/1078-0432.CCR-23-0562.
PMID: 37861398